Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 3/2019

29.08.2017

Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

verfasst von: Santos Castañeda, Carlos González-Juanatey, Miguel A. González-Gay

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The term inflammatory joint disease (IJD) encompasses a group of chronic conditions with predominant joint involvement. They share an increased risk of cardiovascular (CV) complications. However, the implication of the sex in the risk of CV disease in IJD has not been specifically addressed. The aim of this work is to assess the influence of sex on the clinical expression of CV manifestations associated to IJD. With this objective, an update of the current knowledge of the sex influence on CV disease in patients with IJD was conducted. A PubMed database search of the most relevant literature on this topic was performed mainly based on studies published in English over the last 10 years. Although most studies on IJD were not specifically designed to address sex differences regarding CV complications, it seems that men with rheumatoid arthritis (RA) are at higher risk of pericarditis, ischemic heart disease, heart failure (HF) with reduced ejection fraction (EF), and CV mortality than women with RA. In contrast, HF with preserved EF and diastolic dysfunction is more frequent in women with RA. Men with ankylosing spondylitis present more frequently disorders of the conduction system and aortic valvulopathy than women. A limited number of studies addressed CV differences according to sex in psoriatic arthritis. Although there are some differences according to sex in the clinical expression of CV complications in patients with IJD, much research is still needed to better identify the implication of sex in the risk of CV disease in these patients.
Literatur
3.
Zurück zum Zitat Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494CrossRef Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494CrossRef
4.
Zurück zum Zitat Baeten D, Breban M, Lories R, Schett G, Sieper J (2013) Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 65:12–20. doi:10.1002/art.37829 CrossRefPubMed Baeten D, Breban M, Lories R, Schett G, Sieper J (2013) Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 65:12–20. doi:10.​1002/​art.​37829 CrossRefPubMed
5.
Zurück zum Zitat Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331. doi:10.1136/ard.2009.113696 CrossRefPubMed Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331. doi:10.​1136/​ard.​2009.​113696 CrossRefPubMed
7.
Zurück zum Zitat Gargiulo P, Marsico F, Parente A, Paolillo S, Cecere M, Casaretti L, Pellegrino AM, Formisano T, Fabiani I, Soricelli A, Trimarco B, Perrone-Filardi P (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal. Int J Cardiol 170:286–290. doi:10.1016/j.ijcard.2013.11.048 CrossRefPubMed Gargiulo P, Marsico F, Parente A, Paolillo S, Cecere M, Casaretti L, Pellegrino AM, Formisano T, Fabiani I, Soricelli A, Trimarco B, Perrone-Filardi P (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal. Int J Cardiol 170:286–290. doi:10.​1016/​j.​ijcard.​2013.​11.​048 CrossRefPubMed
10.
Zurück zum Zitat Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ (2003) National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 30:958–965PubMed Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ (2003) National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 30:958–965PubMed
11.
Zurück zum Zitat Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019. doi:10.1002/art.10419 CrossRefPubMed Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019. doi:10.​1002/​art.​10419 CrossRefPubMed
13.
Zurück zum Zitat Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411. doi:10.1002/art.20853 CrossRefPubMed Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411. doi:10.​1002/​art.​20853 CrossRefPubMed
14.
Zurück zum Zitat Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732. doi:10.1002/art.20878 CrossRefPubMed Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732. doi:10.​1002/​art.​20878 CrossRefPubMed
16.
Zurück zum Zitat Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412–420. doi:10.1002/art.20855 CrossRefPubMed Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412–420. doi:10.​1002/​art.​20855 CrossRefPubMed
17.
Zurück zum Zitat Crowson CS, Nicola PJ, Kremers HM, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE (2005) How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52:3039–3044. doi:10.1002/art.21349 CrossRefPubMed Crowson CS, Nicola PJ, Kremers HM, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE (2005) How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52:3039–3044. doi:10.​1002/​art.​21349 CrossRefPubMed
18.
Zurück zum Zitat Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60–67. doi:10.1002/art.21560 CrossRefPubMed Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60–67. doi:10.​1002/​art.​21560 CrossRefPubMed
19.
Zurück zum Zitat Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697. doi:10.1002/art.24092 CrossRefPubMed Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697. doi:10.​1002/​art.​24092 CrossRefPubMed
20.
22.
Zurück zum Zitat Castañeda S, Martín-Martínez MA, González-Juanatey C, Llorca J, García-Yébenes MJ, Pérez-Vicente S, Sánchez-Costa JT, Díaz-Gonzalez F, González-Gay MA, CARMA Project Collaborative Group (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum 44:618–626. doi:10.1016/j.semarthrit.2014.12.002 CrossRefPubMed Castañeda S, Martín-Martínez MA, González-Juanatey C, Llorca J, García-Yébenes MJ, Pérez-Vicente S, Sánchez-Costa JT, Díaz-Gonzalez F, González-Gay MA, CARMA Project Collaborative Group (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum 44:618–626. doi:10.​1016/​j.​semarthrit.​2014.​12.​002 CrossRefPubMed
23.
Zurück zum Zitat Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR (2014) The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 73:1301–1308. doi:10.1136/annrheumdis-2013-204715 CrossRefPubMed Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR (2014) The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 73:1301–1308. doi:10.​1136/​annrheumdis-2013-204715 CrossRefPubMed
24.
Zurück zum Zitat Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN (2015) Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 113:916–930. doi:10.1160/TH14-11-0921 CrossRefPubMed Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN (2015) Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 113:916–930. doi:10.​1160/​TH14-11-0921 CrossRefPubMed
26.
27.
Zurück zum Zitat Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M, Ortonne JP, Paul C, Richard MA (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12–29. doi:10.1111/jdv.12163 CrossRefPubMed Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M, Ortonne JP, Paul C, Richard MA (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12–29. doi:10.​1111/​jdv.​12163 CrossRefPubMed
28.
Zurück zum Zitat Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS (1990) Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 69:81–91CrossRef Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS (1990) Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 69:81–91CrossRef
31.
Zurück zum Zitat Roldan CA, Chavez J, Weist P, Qualls CR, Crawford MH (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404CrossRef Roldan CA, Chavez J, Weist P, Qualls CR, Crawford MH (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404CrossRef
33.
Zurück zum Zitat Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56:3583–3587. doi:10.1002/art.22979 CrossRefPubMed Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56:3583–3587. doi:10.​1002/​art.​22979 CrossRefPubMed
35.
Zurück zum Zitat Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT (2014) Diastolic left ventricular dysfunction in ankylosing spondylitis—a systematic review and meta-analysis. Semin Arthritis Rheum 44:14–19. doi:10.1016/j.semarthrit.2014.02.004 CrossRefPubMed Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT (2014) Diastolic left ventricular dysfunction in ankylosing spondylitis—a systematic review and meta-analysis. Semin Arthritis Rheum 44:14–19. doi:10.​1016/​j.​semarthrit.​2014.​02.​004 CrossRefPubMed
36.
Zurück zum Zitat Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH, Lau CS, Tse HF, Yiu KH (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology (Oxford) 54:292–301. doi:10.1093/rheumatology/keu337 CrossRef Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH, Lau CS, Tse HF, Yiu KH (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology (Oxford) 54:292–301. doi:10.​1093/​rheumatology/​keu337 CrossRef
37.
Zurück zum Zitat Nyrnes A, Njølstad I, Mathiesen E, Wilsgaard T, Hansen JB, Skjelbakken T, Jørgensen L, Løchen ML (2012) Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: The Tromsø study. Gend Med 9:536–547.e2. doi:10.1016/j.genm.2012.09.001 CrossRefPubMed Nyrnes A, Njølstad I, Mathiesen E, Wilsgaard T, Hansen JB, Skjelbakken T, Jørgensen L, Løchen ML (2012) Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: The Tromsø study. Gend Med 9:536–547.e2. doi:10.​1016/​j.​genm.​2012.​09.​001 CrossRefPubMed
38.
Zurück zum Zitat Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2014) Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 53:131–137. doi:10.1093/rheumatology/ket338 CrossRef Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2014) Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 53:131–137. doi:10.​1093/​rheumatology/​ket338 CrossRef
42.
Zurück zum Zitat Holmqvist M, Neovius M, Eriksson J, Mantel A, Wallberg- Jonsson S, Jacobsson LT, Askling J (2012) Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308:1350–1356. doi:10.1001/2012.jama.11741 CrossRefPubMed Holmqvist M, Neovius M, Eriksson J, Mantel A, Wallberg- Jonsson S, Jacobsson LT, Askling J (2012) Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308:1350–1356. doi:10.​1001/​2012.​jama.​11741 CrossRefPubMed
43.
44.
Zurück zum Zitat Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479PubMed Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479PubMed
45.
Zurück zum Zitat Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36–40PubMed Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36–40PubMed
46.
Zurück zum Zitat Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172PubMed
47.
Zurück zum Zitat Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP (2011) Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63:3294–3304. doi:10.1002/art.30581 CrossRefPubMed Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP (2011) Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63:3294–3304. doi:10.​1002/​art.​30581 CrossRefPubMed
49.
Zurück zum Zitat Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo J, Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis (2012) Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities. Actas Dermosifiliogr 103(Suppl 1):1–64. doi:10.1016/S0001-7310(12)70001-7 CrossRefPubMed Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo J, Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis (2012) Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities. Actas Dermosifiliogr 103(Suppl 1):1–64. doi:10.​1016/​S0001-7310(12)70001-7 CrossRefPubMed
50.
Zurück zum Zitat Dauden E, Castañeda S, Suarez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL, Working Group on Comorbidity in Psoriasis (2013) Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol 27:1387–1404. doi:10.1111/jdv.12024 CrossRef Dauden E, Castañeda S, Suarez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL, Working Group on Comorbidity in Psoriasis (2013) Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol 27:1387–1404. doi:10.​1111/​jdv.​12024 CrossRef
53.
Zurück zum Zitat Ernste FC, Sanchez-Menendez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 67:1015–1021. doi:10.1002/acr.22536 CrossRef Ernste FC, Sanchez-Menendez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 67:1015–1021. doi:10.​1002/​acr.​22536 CrossRef
58.
Zurück zum Zitat Bergstrom U, Jacobsson LT, Nilsson JA, Berglund G, Turesson C (2011) Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 50:2005–2013. doi:10.1093/rheumatology/ker258 CrossRef Bergstrom U, Jacobsson LT, Nilsson JA, Berglund G, Turesson C (2011) Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 50:2005–2013. doi:10.​1093/​rheumatology/​ker258 CrossRef
62.
Zurück zum Zitat Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA (2013) Metabolic syndrome in rheumatoid arthritis. Mediat Inflamm 2013:710928. doi:10.1155/2013/710928 CrossRef Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA (2013) Metabolic syndrome in rheumatoid arthritis. Mediat Inflamm 2013:710928. doi:10.​1155/​2013/​710928 CrossRef
63.
Zurück zum Zitat Giles JT, Allison M, Blumenthal RS, Post W, Gelber AC, Petri M, Tracy R, Szklo M, Bathon JM (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173–3182. doi:10.1002/art.27629 CrossRefPubMedPubMedCentral Giles JT, Allison M, Blumenthal RS, Post W, Gelber AC, Petri M, Tracy R, Szklo M, Bathon JM (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173–3182. doi:10.​1002/​art.​27629 CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46:1477–1482. doi:10.1093/rheumatology/kem169 CrossRef Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46:1477–1482. doi:10.​1093/​rheumatology/​kem169 CrossRef
65.
Zurück zum Zitat Popa CD, Arts E, Fransen J, van Riel PL (2012) Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediat Inflamm 2012:785946. doi:10.1155/2012/785946 CrossRef Popa CD, Arts E, Fransen J, van Riel PL (2012) Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediat Inflamm 2012:785946. doi:10.​1155/​2012/​785946 CrossRef
69.
Zurück zum Zitat van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MH, Dijkmans BA, Nurmohamed MT (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473–1477. doi:10.1136/ard.2005.050443 CrossRefPubMedPubMedCentral van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MH, Dijkmans BA, Nurmohamed MT (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473–1477. doi:10.​1136/​ard.​2005.​050443 CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60:1324–1330. doi:10.1002/art.24492 CrossRefPubMed van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60:1324–1330. doi:10.​1002/​art.​24492 CrossRefPubMed
71.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrúa C, Testa A, Llorca J (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32:1219–1223PubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrúa C, Testa A, Llorca J (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32:1219–1223PubMed
72.
Zurück zum Zitat Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132. doi:10.1002/art.22482 CrossRefPubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132. doi:10.​1002/​art.​22482 CrossRefPubMed
76.
Zurück zum Zitat Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114:647–652CrossRef Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114:647–652CrossRef
77.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:287–293. doi:10.1002/art.22530 CrossRefPubMed Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:287–293. doi:10.​1002/​art.​22530 CrossRefPubMed
78.
Zurück zum Zitat Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S (2011) Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38:723–729. doi:10.3899/jrheum.100668 CrossRefPubMed Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S (2011) Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38:723–729. doi:10.​3899/​jrheum.​100668 CrossRefPubMed
79.
Zurück zum Zitat López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA (2016) Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 15:1013–1030. doi:10.1016/j.autrev.2016.07.026 CrossRefPubMed López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA (2016) Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 15:1013–1030. doi:10.​1016/​j.​autrev.​2016.​07.​026 CrossRefPubMed
80.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA (2003) Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 82:407–413. doi:10.1097/01.md.0000101572.76273.60 CrossRef Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA (2003) Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 82:407–413. doi:10.​1097/​01.​md.​0000101572.​76273.​60 CrossRef
81.
Zurück zum Zitat Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in PsA patients without clinically evident CVD or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080. doi:10.1002/art.22884 CrossRefPubMed Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in PsA patients without clinically evident CVD or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080. doi:10.​1002/​art.​22884 CrossRefPubMed
82.
Zurück zum Zitat Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88:358–365. doi:10.1097/MD.0b013e3181c10773 CrossRef Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88:358–365. doi:10.​1097/​MD.​0b013e3181c10773​ CrossRef
83.
Zurück zum Zitat Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA (2014) Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 73:722–727. doi:10.1136/annrheumdis-2012-203101 CrossRefPubMed Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA (2014) Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 73:722–727. doi:10.​1136/​annrheumdis-2012-203101 CrossRefPubMed
84.
Zurück zum Zitat Corrales A, Parra JA, González-Juanatey C, Rueda-Gotor J, Blanco R, Llorca J, González-Gay MA (2013) Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 72:1764–1770. doi:10.1136/annrheumdis-2013-203688 CrossRefPubMed Corrales A, Parra JA, González-Juanatey C, Rueda-Gotor J, Blanco R, Llorca J, González-Gay MA (2013) Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 72:1764–1770. doi:10.​1136/​annrheumdis-2013-203688 CrossRefPubMed
85.
Zurück zum Zitat Rueda-Gotor J, Llorca J, Corrales A, Blanco R, Fuentevilla P, Portilla V, Expósito R, Mata C, Pina T, González-Juanatey C, González-Gay MA (2016) Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. Clin Exp Rheumatol 34:885–892PubMed Rueda-Gotor J, Llorca J, Corrales A, Blanco R, Fuentevilla P, Portilla V, Expósito R, Mata C, Pina T, González-Juanatey C, González-Gay MA (2016) Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. Clin Exp Rheumatol 34:885–892PubMed
86.
Zurück zum Zitat Hollan I, Prayson R, Saatvedt K, Almdahl SM, Nossent HC, Mikkelsen K, Liang MH, Kvelstad IL, Aamodt G, Førre OT (2008) Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients. Circ J 72:1986–1992CrossRef Hollan I, Prayson R, Saatvedt K, Almdahl SM, Nossent HC, Mikkelsen K, Liang MH, Kvelstad IL, Aamodt G, Førre OT (2008) Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients. Circ J 72:1986–1992CrossRef
87.
Zurück zum Zitat Kitas GD, Banks M, Bacon PA (2001) Cardiac involvement in rheumatoid disease. Clin Med (Lond) 1:18–21CrossRef Kitas GD, Banks M, Bacon PA (2001) Cardiac involvement in rheumatoid disease. Clin Med (Lond) 1:18–21CrossRef
88.
Zurück zum Zitat Hurd ER (1979) Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 8:151–176CrossRef Hurd ER (1979) Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 8:151–176CrossRef
89.
Zurück zum Zitat Jurik AG, Graudal H (1986) Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int 6:37–42CrossRef Jurik AG, Graudal H (1986) Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int 6:37–42CrossRef
90.
Zurück zum Zitat Escalante A, Kaufman RL, Quismorio FP Jr, Beardmore TD (1990) Cardiac compression in rheumatoid pericarditis. Semin Arthritis Rheum 20:148–163CrossRef Escalante A, Kaufman RL, Quismorio FP Jr, Beardmore TD (1990) Cardiac compression in rheumatoid pericarditis. Semin Arthritis Rheum 20:148–163CrossRef
91.
Zurück zum Zitat Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2004) Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 33:231–238CrossRef Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2004) Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 33:231–238CrossRef
93.
Zurück zum Zitat Kang H, Baron M (2004) Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 31:1001–1003PubMed Kang H, Baron M (2004) Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 31:1001–1003PubMed
94.
Zurück zum Zitat Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35:333–339. doi:10.1016/j.semarthrit.2005.12.002 CrossRefPubMed Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35:333–339. doi:10.​1016/​j.​semarthrit.​2005.​12.​002 CrossRefPubMed
96.
Zurück zum Zitat Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849–1865CrossRef Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849–1865CrossRef
97.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200. doi:10.1093/eurheartj/ehw128 CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200. doi:10.​1093/​eurheartj/​ehw128 CrossRef
98.
Zurück zum Zitat Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550. doi:10.1093/eurheartj/ehm037 CrossRefPubMed Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550. doi:10.​1093/​eurheartj/​ehm037 CrossRefPubMed
99.
Zurück zum Zitat Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271. doi:10.1016/j.jacc.2013.02.092 CrossRef Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271. doi:10.​1016/​j.​jacc.​2013.​02.​092 CrossRef
100.
Zurück zum Zitat Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105:1503–1508CrossRef Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105:1503–1508CrossRef
101.
Zurück zum Zitat Fukuta H, Little WC (2007) Diagnosis of diastolic heart failure. Curr Cardiol Rep 9:224–228CrossRef Fukuta H, Little WC (2007) Diagnosis of diastolic heart failure. Curr Cardiol Rep 9:224–228CrossRef
102.
Zurück zum Zitat Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202CrossRef Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202CrossRef
105.
Zurück zum Zitat Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65:534–543. doi:10.1002/acr.21861 CrossRef Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65:534–543. doi:10.​1002/​acr.​21861 CrossRef
108.
Zurück zum Zitat Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84. doi:10.1016/j.jacc.2005.09.022 CrossRefPubMed Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84. doi:10.​1016/​j.​jacc.​2005.​09.​022 CrossRefPubMed
109.
Zurück zum Zitat Centers for Medicare & Medicaid Services (2012) Chronic conditions among Medicare Beneficiaries. Chartbook, 2012th edn. Centers for Medicare & Medicaid Services, Baltimore Centers for Medicare & Medicaid Services (2012) Chronic conditions among Medicare Beneficiaries. Chartbook, 2012th edn. Centers for Medicare & Medicaid Services, Baltimore
110.
Zurück zum Zitat van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA (2014) Comorbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16:103–111. doi:10.1002/ejhf.30 CrossRefPubMed van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA (2014) Comorbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16:103–111. doi:10.​1002/​ejhf.​30 CrossRefPubMed
111.
Zurück zum Zitat He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996–1002CrossRef He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996–1002CrossRef
113.
Zurück zum Zitat Mutru O, Laakso M, Isomäki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77CrossRef Mutru O, Laakso M, Isomäki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77CrossRef
115.
Zurück zum Zitat Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE (2011) Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 63:729–734. doi:10.1002/acr.20425 CrossRef Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE (2011) Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 63:729–734. doi:10.​1002/​acr.​20425 CrossRef
117.
Zurück zum Zitat Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, Yu CM (2011) High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 38:1363–1370. doi:10.3899/jrheum.101136 CrossRefPubMed Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, Yu CM (2011) High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 38:1363–1370. doi:10.​3899/​jrheum.​101136 CrossRefPubMed
118.
119.
Zurück zum Zitat Bergner DW, Goldberger JJ (2010) Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J 17:117–129PubMed Bergner DW, Goldberger JJ (2010) Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J 17:117–129PubMed
121.
Zurück zum Zitat London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431–H441. doi:10.1152/ajpheart.00431.2002 CrossRefPubMed London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431–H441. doi:10.​1152/​ajpheart.​00431.​2002 CrossRefPubMed
122.
Zurück zum Zitat Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G (2006) Electrical remodeling of cardiacmyocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 290:H2098–H2107. doi:10.1152/ajpheart.00097.2005 CrossRefPubMed Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G (2006) Electrical remodeling of cardiacmyocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 290:H2098–H2107. doi:10.​1152/​ajpheart.​00097.​2005 CrossRefPubMed
123.
Zurück zum Zitat Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:517–584. doi:10.1161/STR.0b013e3181fcb238 CrossRefPubMed Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:517–584. doi:10.​1161/​STR.​0b013e3181fcb238​ CrossRefPubMed
125.
127.
128.
Zurück zum Zitat Dilaveris PE, Gialafos JE (2001) P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165CrossRef Dilaveris PE, Gialafos JE (2001) P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165CrossRef
130.
Zurück zum Zitat Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, Yalcin F (2007) P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 27:813–818. doi:10.1007/s00296-007-0307-8 CrossRefPubMed Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, Yalcin F (2007) P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 27:813–818. doi:10.​1007/​s00296-007-0307-8 CrossRefPubMed
131.
Zurück zum Zitat Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT (2010) The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 39:38–41. doi:10.3109/03009740903096101 CrossRefPubMed Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT (2010) The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 39:38–41. doi:10.​3109/​0300974090309610​1 CrossRefPubMed
133.
Zurück zum Zitat Bisoendial RJ, Levi M, Tak PP, Stroes ES (2010) The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events. Semin Thromb Hemost 36:452–457. doi:10.1055/s-0030-1254054 CrossRefPubMed Bisoendial RJ, Levi M, Tak PP, Stroes ES (2010) The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events. Semin Thromb Hemost 36:452–457. doi:10.​1055/​s-0030-1254054 CrossRefPubMed
136.
Zurück zum Zitat Matta F, Singala R, Yaekoub A, Najjar R, Stein PD (2009) Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 101:134–138CrossRef Matta F, Singala R, Yaekoub A, Najjar R, Stein PD (2009) Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 101:134–138CrossRef
140.
Zurück zum Zitat Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y (2013) The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 72:1182–1187. doi:10.1136/annrheumdis-2012-201669 CrossRefPubMed Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y (2013) The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 72:1182–1187. doi:10.​1136/​annrheumdis-2012-201669 CrossRefPubMed
142.
Zurück zum Zitat Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, Sung FC, Kao CH (2014) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 73:1774–1780. doi:10.1136/annrheumdis-2013-203380 CrossRefPubMed Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, Sung FC, Kao CH (2014) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 73:1774–1780. doi:10.​1136/​annrheumdis-2013-203380 CrossRefPubMed
143.
Zurück zum Zitat Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788. doi:10.1016/S0735-1097(96)00380-4 CrossRefPubMed Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788. doi:10.​1016/​S0735-1097(96)00380-4 CrossRefPubMed
144.
Zurück zum Zitat Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr (2007) Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Am Heart J 153:1074–1080. doi:10.1016/j.ahj.2007.03.016 CrossRefPubMed Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr (2007) Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Am Heart J 153:1074–1080. doi:10.​1016/​j.​ahj.​2007.​03.​016 CrossRefPubMed
145.
Zurück zum Zitat Tasevska-Dinevska G, Kennedy LM, Nilsson PM, Willenheimer R (2009) Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmo preventive project. Eur J Epidemiol 24:249–257. doi:10.1007/s10654-009-9320-4 CrossRefPubMed Tasevska-Dinevska G, Kennedy LM, Nilsson PM, Willenheimer R (2009) Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmo preventive project. Eur J Epidemiol 24:249–257. doi:10.​1007/​s10654-009-9320-4 CrossRefPubMed
146.
Zurück zum Zitat Conde-Martel A, Arkuch ME, Formiga F, Manzano-Espinosa L, Aramburu-Bodas O, Gonzalez-Franco A, Davila-Ramos MF, Suarez-Pedreira I, Herrero-Domingo A, Montero-Perez-Barquero M (2015) Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA Registry. Rev Clin Esp 215:363–370. doi:10.1016/j.rce.2015.02.010 CrossRefPubMed Conde-Martel A, Arkuch ME, Formiga F, Manzano-Espinosa L, Aramburu-Bodas O, Gonzalez-Franco A, Davila-Ramos MF, Suarez-Pedreira I, Herrero-Domingo A, Montero-Perez-Barquero M (2015) Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA Registry. Rev Clin Esp 215:363–370. doi:10.​1016/​j.​rce.​2015.​02.​010 CrossRefPubMed
147.
Zurück zum Zitat Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals (2009) Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol 104:107–115. doi:10.1016/j.amjcard.2009.02.057 CrossRefPubMed Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals (2009) Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol 104:107–115. doi:10.​1016/​j.​amjcard.​2009.​02.​057 CrossRefPubMed
148.
Zurück zum Zitat Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134CrossRef Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134CrossRef
149.
Zurück zum Zitat Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10:140–148. doi:10.1016/j.ejheart.2007.12.012 CrossRefPubMed Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10:140–148. doi:10.​1016/​j.​ejheart.​2007.​12.​012 CrossRefPubMed
150.
Zurück zum Zitat Cui X, Kaspar M, Zhu H, Stork S, Ertl G, Zhou J, Ge J, Angermann CE (2014) Clinical characteristics, treatment and survival in patients with systolic heart failure—comparative assessment of a Chinese and a German cohort. Int J Cardiol 176:1388–1390. doi:10.1016/j.ijcard.2014.08.026 CrossRefPubMed Cui X, Kaspar M, Zhu H, Stork S, Ertl G, Zhou J, Ge J, Angermann CE (2014) Clinical characteristics, treatment and survival in patients with systolic heart failure—comparative assessment of a Chinese and a German cohort. Int J Cardiol 176:1388–1390. doi:10.​1016/​j.​ijcard.​2014.​08.​026 CrossRefPubMed
151.
Zurück zum Zitat Adams KF Jr, Sueta CA, Gheorghiade M, O’Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM (1999) Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99:1816–1821CrossRef Adams KF Jr, Sueta CA, Gheorghiade M, O’Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM (1999) Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99:1816–1821CrossRef
152.
Zurück zum Zitat Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68. doi:10.1136/annrheumdis-2013-204223 CrossRefPubMed Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68. doi:10.​1136/​annrheumdis-2013-204223 CrossRefPubMed
153.
Zurück zum Zitat Moltó A, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgoçmen S, van Gaalen F, Dougados M (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75:1016–1023. doi:10.1136/annrheumdis-2015-208174 CrossRefPubMed Moltó A, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgoçmen S, van Gaalen F, Dougados M (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75:1016–1023. doi:10.​1136/​annrheumdis-2015-208174 CrossRefPubMed
154.
155.
Zurück zum Zitat Cheng RK, CoxM NML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC (2014) Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168:721–730. doi:10.1016/j.ahj.2014.07.008 CrossRefPubMed Cheng RK, CoxM NML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC (2014) Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168:721–730. doi:10.​1016/​j.​ahj.​2014.​07.​008 CrossRefPubMed
156.
Zurück zum Zitat Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA (2014) Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum 44:1–8. doi:10.1016/j.semarthrit.2014.01.002 CrossRefPubMed Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA (2014) Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum 44:1–8. doi:10.​1016/​j.​semarthrit.​2014.​01.​002 CrossRefPubMed
157.
Zurück zum Zitat Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S (2015) Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int 35:445–458. doi:10.1007/s00296-014-3196-7 CrossRefPubMed Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S (2015) Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int 35:445–458. doi:10.​1007/​s00296-014-3196-7 CrossRefPubMed
158.
Zurück zum Zitat Torre-Alonso JC, Carmona L, Moreno M, Galíndez E, Babío J, Zarco P, Linares L, Collantes-Estevez E, Barrial MF, Hermosa JC, Coto P, Suárez C, Almodóvar R, Luelmo J, Castañeda S, Gratacós J (2017) Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain. Rheumatol Int. doi:10.1007/s00296-017-3702-9 Torre-Alonso JC, Carmona L, Moreno M, Galíndez E, Babío J, Zarco P, Linares L, Collantes-Estevez E, Barrial MF, Hermosa JC, Coto P, Suárez C, Almodóvar R, Luelmo J, Castañeda S, Gratacós J (2017) Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain. Rheumatol Int. doi:10.​1007/​s00296-017-3702-9
159.
Zurück zum Zitat González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L (2017) Recommendations for the management of comorbidity in patients with axial spondyloarthritis in clinical practice. Reumatol Clin S1699-258X(17):30081–30085. doi:10.1016/j.Reuma.2017.03.011 [Epub ahead of print] English, SpanishCrossRef González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L (2017) Recommendations for the management of comorbidity in patients with axial spondyloarthritis in clinical practice. Reumatol Clin S1699-258X(17):30081–30085. doi:10.​1016/​j.​Reuma.​2017.​03.​011 [Epub ahead of print] English, SpanishCrossRef
Metadaten
Titel
Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
verfasst von
Santos Castañeda
Carlos González-Juanatey
Miguel A. González-Gay
Publikationsdatum
29.08.2017
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 3/2019
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-017-8635-2

Weitere Artikel der Ausgabe 3/2019

Clinical Reviews in Allergy & Immunology 3/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.